Form 4: Tenet Healthcare Director Receives Equity Grant

Director Meghan Fitzgerald was granted 1,188 restricted stock units as part of Tenet Healthcare's incentive plan.

Summary

• Director Meghan Fitzgerald received a grant of 1,188 restricted stock units (RSUs) on May 27, 2026.
• Each RSU represents the economic equivalent of one share of Tenet Healthcare common stock.
• The units are scheduled to vest on May 27, 2027, the first anniversary of the grant date.
• The reporting person has the option to receive up to 37% of the vested units in cash rather than shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Potential dilution of existing shareholders upon the eventual issuance of common stock, though the amount is immaterial relative to total shares outstanding.

Future Outlook

The restricted stock units will vest on May 27, 2027, at which point the director may receive shares or a cash equivalent for up to 37% of the grant.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practice in the healthcare sector to ensure director alignment with company performance.

Comparison to Industry Standards

• The grant of RSUs to directors is consistent with standard compensation practices for S&P 500 healthcare companies.
• The one-year vesting period is a common retention and alignment mechanism used by peers such as HCA Healthcare and Universal Health Services.

Stakeholder Impact

• Minimal impact on shareholders due to the small size of the equity grant.

Next Steps

• Vesting of the 1,188 restricted stock units on May 27, 2027.

Key Dates

Keywords

Tenet Healthcare, THC, Form 4, Insider Trading, Equity Compensation, Director Compensation